← Back to headlines
Vaxcyte Announces $632.5M Stock Offering After Bullish Cantor Fitzgerald Rating
Vaxcyte (PCVX) is proceeding with a $632.5 million stock offering, following a positive rating from Cantor Fitzgerald.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
